BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Subscribe to see BioLife Solutions, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioLife Solutions, Inc. is a medical - instruments & supplies company headquartered in Bothell, United States. It is publicly listed (BLFS) with a market capitalisation of $1.9B. Xcout tracks 18 named people at BioLife Solutions, Inc., including Roderick de Greef (Chief Executive Officer & Chairman).
As of 16 November 2026. Source: Xcout Intel.
12 more named people on record for BioLife Solutions, Inc., with roles, board committees and tenure — see the full roster →
12 corporate events on record, with sources — see the full timeline →
A few of BioLife Solutions, Inc.'s closest competitors — see the full list of competitors and alternatives →
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand. Repligen also boasts an extensive suite of filtration products. This includes XCell Alternating Tangential Flow systems, which are filtration devices utilized in upstream perfusion and cell culture processing. For downstream applications like biologic drug concentration and formulation, they provide TangenX flat sheet cassettes. Other filtration offerings encompass KrosFlo tangential flow filtration and tangential flow depth filtration systems, Spectra/Por laboratory and process dialysis products, SpectraFlo dynamic dialysis systems, and ProConnex single-use hollow fibers. Furthermore, Repligen addresses process analytics with its slope spectroscopy systems, branded as SoloVPE, FlowVPE, and FlowVPX. Their clientele is broad, consisting of life sciences organizations, biopharmaceutical and diagnostics companies, laboratory researchers, and contract manufacturing organizations. Repligen also collaborates with partners, such as Navigo Proteins GmbH, on the development of various affinity ligands. The corporation was founded in 1981 and maintains its corporate headquarters in Waltham, Massachusetts.
ThermoGenesis Group, Inc. develops and commercializes automated cell processing systems, devices, and CDMO services for the cell and gene therapy industry. The company provides closed-system solutions for clinical biobanking, cellular processing, and manufacturing to support researchers, clinicians, and biomanufacturing organizations.
Biologics Modular, LLC designs and manufactures pre-constructed, container-based modular cleanrooms, biomanufacturing suites, and research facilities. The company serves pharmaceutical manufacturers, health science service providers, and educational institutions by providing scalable, transportable, and CGMP-validated production environments.
Headquartered in Shanghai, BioLink is a high-tech group enterprise and life science partner focused on the R&D and manufacturing of process solutions, equipment, and products for biopharmaceutical companies and institutions.
Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems. Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.
GenScript Biotech Corporation was founded in New Jersey in 2002 and accelerates innovation in biotechnology and healthcare. The company provides custom services and products to help researchers and corporate clients advance scientific discovery.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about BioLife Solutions, Inc.? Suggest a correction · Work at BioLife Solutions, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.